Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 9,374,000 | 9,260,000 | 9,024,000 | 8,671,000 | 8,150,000 |
| Cost of Goods | 2,488,000 | 2,475,000 | 2,529,000 | 2,225,000 | 2,182,000 |
| Gross Profit | 6,886,000 | 6,785,000 | 6,495,000 | 6,446,000 | 5,968,000 |
| Operating Expenses | 4,551,000 | 5,144,000 | 4,516,000 | 4,482,000 | 3,910,000 |
| Operating Income | 2,335,000 | 1,641,000 | 1,979,000 | 1,964,000 | 2,058,000 |
| Interest Expense | 53,000 | 57,000 | 76,000 | 75,000 | 58,000 |
| Other Income | 184,000 | 166,000 | 160,000 | 80,000 | 212,000 |
| Pre-tax Income | 2,466,000 | 1,750,000 | 2,063,000 | 1,969,000 | 2,212,000 |
| Income Tax | 374,000 | 208,000 | 271,000 | 317,000 | 373,000 |
| Net Income Continuous | 2,092,000 | 1,542,000 | 1,792,000 | 1,652,000 | 1,839,000 |
| Net Income Discontinuous | 79,000 | 121,000 | 78,000 | 61,000 | 117,000 |
| Minority Interests | 2,000 | 9,000 | 3,000 | 6,000 | 9,000 |
| Net Income | $2,169,000 | $1,654,000 | $1,867,000 | $1,707,000 | $1,947,000 |
| EPS Basic Total Ops | 0.92 | 0.70 | 0.80 | 0.73 | 0.83 |
| EPS Basic Continuous Ops | 0.89 | 0.65 | 0.77 | 0.70 | 0.78 |
| EPS Basic Discontinuous Ops | 0.03 | 0.05 | 0.03 | 0.03 | 0.05 |
| EPS Diluted Total Ops | 0.92 | 0.70 | 0.79 | 0.72 | 0.83 |
| EPS Diluted Continuous Ops | 0.89 | 0.64 | 0.76 | 0.70 | 0.78 |
| EPS Diluted Discontinuous Ops | 0.03 | 0.06 | 0.03 | 0.02 | 0.05 |
| EBITDA(a) | $2,875,000 | $1,641,000 | $2,542,000 | $2,372,000 | $2,486,000 |